MYTREX A Drug Patent Profile
Which patents cover Mytrex A, and what generic alternatives are available?
Mytrex A is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in MYTREX A is neomycin sulfate; triamcinolone acetonide. There is one drug master file entry for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MYTREX A?
- What are the global sales for MYTREX A?
- What is Average Wholesale Price for MYTREX A?
Summary for MYTREX A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | MYTREX A at DailyMed |
US Patents and Regulatory Information for MYTREX A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | MYTREX A | neomycin sulfate; triamcinolone acetonide | CREAM;TOPICAL | 062598-001 | Jul 21, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Savage Labs | MYTREX A | neomycin sulfate; triamcinolone acetonide | OINTMENT;TOPICAL | 062609-001 | May 23, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
